Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: gsk
gsk
Update Il y a 6 ans
A Multicentre, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Efficacy of Rosiglitazone When Administered to Patients With Type 2 Diabetes Mellitus
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An open study of the safety and immunogenicity of DTPa-HBV-IPV vaccine administered as a three dose series or in a sequential IPV/OPV schedule at 2, 4, and 6 months of age
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Phase I clinical investigation of paroxetine. The pharmacokinetics, safety and tolerance of single and repeat oral administration of paroxetine in healthy volunteers
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An Evaluation of the Safety, Tolerability, Pharmacokinetics and Protein Binding of BRL 49653C in Patients with Hepatic Impairment
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An interaction study with subcutaneously administered Org31540/SR90107A and oral warfarin in healthy male volunteers (Protocol 63108)
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Immunogenicity and protective efficacy of GlaxoSmithKline (GSK) recombinant-DNA hepatitis B vaccine (10 (g) in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An open, multicentric, phase IV clinical trial to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ combined diphtheria-tetanus-acellular pertussis vaccine (Infanrix™) administered to healthy infants at 2, 4 and 6 months of age
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of TRIUMEQ administered in Korean subjects for treatment of HIV-1 infection in real life practice
TRIUMEQ is approved on 9th Sep 2015 in Korea. We aimed to conduct PMS to monitor the safety and effectiveness of TRIUMEQ based on the data collected in a real world clinical practice according to PMS ...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A phase II, double-blind, randomized, placebo-controlled, dose-escalating, stepwise study to assess safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ live attenuated human rotavirus (HRV) vaccine in healthy infants previously uninfected with human rotavirus
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
11
12
13
14
15
16
17
18
19
20
Next